Loading organizations...
New Mountain Capital operates as an investment firm, actively managing private equity, credit, and net lease capital. The firm employs an intensive fundamental research methodology coupled with a growth-oriented, value-add investment approach. Their strategy concentrates on business building within economically acyclical industries, particularly focusing on sectors such as healthcare, software, business services, and data.
The firm was established in 1999 by Steven Klinsky. Klinsky brought a significant pedigree from his prior roles, including a partnership at Forstmann Little & Company and co-founding the Leverage Buyout Group at Goldman Sachs & Co. His founding insight revolved around generating consistent long-term returns through proactive business building and growth, moving away from over-reliance on excessive leverage.
New Mountain Capital primarily serves its limited partners by delivering high and consistent returns through its strategic investments, while also supporting the development of its portfolio companies. The firm’s overarching vision is to continuously build great businesses, systematically cultivating expertise across diverse sectors to foster sustained growth and generate enduring value.
Key people at New Mountain Capital.
New Mountain Capital was founded in 1999 by Steven Klinsky (Founder, CEO & Managing Director).
New Mountain Capital was founded in 1999 by Steven Klinsky (Founder, CEO & Managing Director).
Key people at New Mountain Capital.
New Mountain Capital is a New York City-based alternative investment firm specializing in growth-oriented private equity, credit, and net lease strategies focused on defensive growth industries—sectors with sustainable, noncyclical demand like life sciences, healthcare tech, and specialized software.[1][2][4] Its mission centers on acquiring controlling or minority stakes in high-quality, mid-sized leaders (typically $100M–$1B enterprise value, investing $100M–$500M per deal), then building them through operational improvements rather than heavy leverage, emphasizing business growth over risk.[2][4] The firm's investment philosophy prioritizes top-down sector selection in acyclical niches with strong cash flows, high barriers to entry, and downside protection, enabling proactive investments before auctions.[1][2] With ~$60B in assets under management as of mid-2025 and over 80 businesses invested in since 2000, New Mountain influences the startup and mid-market ecosystem by scaling family-owned or under-optimized firms into industry dominators, often forging novel strategies in predictable industries.[1][2][4]
Key sectors include life science supplies/biomanufacturing, "must-have" information/data services, technology-enabled business services, human capital management, financial services/tech, specialized software, defensive consumer products, healthcare/health tech, infrastructure services, and digital marketing.[2]
Founded in 1999 by Robert H. (Rob) Klinsky, a former Forstmann Little executive, New Mountain Capital emerged from Klinsky's vision to target mid-sized companies in resilient industries, capitalizing on opportunities overlooked by larger peers.[1][3] Klinsky, leveraging his buyout experience, built the firm around a growth-building model using modest debt, starting with a focus on U.S. family-owned businesses lacking acquisition history or international scale.[1] The firm evolved from pure private equity to diversified strategies including credit and net lease by the 2010s, expanding offices to Europe and Asia while maintaining a New York HQ.[1][4] Pivotal moments include Blackstone's 9% stake acquisition in 2018, raising over $10B across funds in 2021, ranking 37th in PEI 300 by 2024, and launching New Mountain Wealth Solutions in January 2025 under Raleigh Peters to serve RIAs.[1][3][4] This progression reflects annual team debates on sector evolution, adapting to shifts while prioritizing outperformance—returning more capital than invested by 2024.[1]
New Mountain rides the defensive growth wave in tech-adjacent sectors like health tech, biomanufacturing, and digital transformation, where "must-have" services thrive amid economic volatility and AI-driven efficiencies.[2][4] Timing aligns with post-pandemic supply chain resilience and rising demand for noncyclical tech (e.g., revenue integrity software, human capital tools), as mid-sized firms offer untapped scale before megafunds crowd in.[1][2] Market forces favoring them include investor appetite for lower-risk PE—evident in oversubscribed funds and commitments from insurers like Fubon Life—plus barriers in specialized niches shielding from competition.[3][4] The firm shapes the ecosystem by transforming regional players into globals (e.g., Avantor on Fortune 500, OneDigital sale to Onex), fostering innovation in underserved areas like field services tech and providing operating expertise that boosts startup-like agility in mature businesses.[1][4][5]
New Mountain's momentum—fueled by record fundraises, AUM growth to $60B, and expansions like Mexico City office and Wealth Solutions—positions it to dominate mid-market defensive tech plays.[3][4] Upcoming trends like AI-biomanufacturing integration and RIA tech demand will amplify its edge, with fresh capital (e.g., NMP VII undrawn, new non-control Fund II) targeting sectors evolving via annual foresight sessions.[1][3] Influence may evolve toward more global minority stakes and net lease in critical infrastructure, sustaining outsized returns in a high-rate environment. This disciplined builder of resilient "mountains" exemplifies how focused growth outpaces cyclical frenzy, echoing its founding bet on predictability over hype.[1][2]
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 28, 2019 | Sensely | $15.0M Other Equity | Nadeem G. Khan | Chengwei Capital, Mojo Partners, Nippon Life Insurance Company, Pegasus Tech Ventures, Silicon Valley Bank, Sojitz Corporation, Susquehanna International Group, Zuellig Pharma |